A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse

Nat Genet. 2005 Aug;37(8):803-5. doi: 10.1038/ng1603. Epub 2005 Jul 17.

Abstract

The mouse mutation fragilitas ossium (fro) leads to a syndrome of severe osteogenesis and dentinogenesis imperfecta with no detectable collagen defect. Positional cloning of the locus identified a deletion in the gene encoding neutral sphingomyelin phosphodiesterase 3 (Smpd3) that led to complete loss of enzymatic activity. Our knowledge of SMPD3 function is consistent with the pathology observed in mutant mice and provides new insight into human pathologies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dentinogenesis Imperfecta / enzymology
  • Dentinogenesis Imperfecta / genetics*
  • Gene Deletion*
  • Mice
  • Mice, Mutant Strains
  • Mutation
  • Osteogenesis Imperfecta / enzymology
  • Osteogenesis Imperfecta / genetics*
  • Sphingomyelin Phosphodiesterase

Substances

  • Smpd3 protein, mouse
  • Sphingomyelin Phosphodiesterase